ClinConnect ClinConnect Logo
Search / Trial NCT06533020

Long-term Outcomes of Complex Conversion Total Hip Arthroplasty

Launched by UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL · Jul 29, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at the long-term results of complex and conversion total hip replacement surgeries. The researchers want to understand how these surgeries affect patients over time, particularly focusing on their mobility and overall quality of life. To do this, they will review past medical records and conduct follow-up visits to gather information from patients about their experiences and any changes they may have noticed since their surgery.

To be eligible for the study, participants should be between the ages of 65 and 74 and must have had a total hip replacement done by a UNC Health-affiliated doctor at least five years ago, or a more complicated version of the surgery at least ten years ago. Participants need to be comfortable communicating in English and willing to share their health information with the research team. If you join this study, you can expect to provide feedback about your health and well-being, which will help doctors understand the effectiveness of these surgeries over the years.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Having undergone a conversion total hip arthroplasty (THA) more than five years ago or a complex THA more than ten years ago done by a UNC Health-affiliated physician
  • Willingness to receive follow-up care from a UNC Health-affiliated physician or provide outcome data regarding this surgical intervention
  • Able to speak and read English
  • Able to consent to participation
  • Exclusion Criteria:
  • Less than 18 years of age
  • Incarcerated status

About University Of North Carolina, Chapel Hill

The University of North Carolina at Chapel Hill (UNC) is a leading research institution renowned for its commitment to advancing health and science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, UNC conducts cutting-edge research across various fields, including medicine, public health, and biomedical sciences. The university is dedicated to improving patient care and health outcomes by translating its research findings into practical applications. UNC’s clinical trials are designed to evaluate new therapies, interventions, and technologies, ensuring that they meet the highest ethical and scientific standards while fostering a culture of inclusivity and community engagement.

Locations

Chapel Hill, North Carolina, United States

Patients applied

0 patients applied

Trial Officials

Alecia Rajesh

Principal Investigator

University of North Carolina, Chapel Hill

Ishani Deliwala

Principal Investigator

University of North Carolina, Chapel Hill

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported